SEPA vs. HSAQ, DXR, NSPR, SRTS, AMIX, CTSO, CTCX, GBS, LUCD, and ICU
Should you be buying SEP Acquisition stock or one of its competitors? The main competitors of SEP Acquisition include Health Sciences Acquisitions Co. 2 (HSAQ), Daxor (DXR), InspireMD (NSPR), Sensus Healthcare (SRTS), Autonomix Medical (AMIX), Cytosorbents (CTSO), Carmell (CTCX), GBS (GBS), Lucid Diagnostics (LUCD), and SeaStar Medical (ICU). These companies are all part of the "surgical & medical instruments" industry.
SEP Acquisition (NASDAQ:SEPA) and Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, earnings, risk, valuation, profitability, community ranking, media sentiment and analyst recommendations.
3.7% of SEP Acquisition shares are held by institutional investors. Comparatively, 89.7% of Health Sciences Acquisitions Co. 2 shares are held by institutional investors. 20.0% of SEP Acquisition shares are held by insiders. Comparatively, 21.9% of Health Sciences Acquisitions Co. 2 shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
SEP Acquisition and Health Sciences Acquisitions Co. 2 both received 0 outperform votes by MarketBeat users.
SEP Acquisition has a beta of 0.08, indicating that its share price is 92% less volatile than the S&P 500. Comparatively, Health Sciences Acquisitions Co. 2 has a beta of 0.09, indicating that its share price is 91% less volatile than the S&P 500.
In the previous week, Health Sciences Acquisitions Co. 2 had 2 more articles in the media than SEP Acquisition. MarketBeat recorded 3 mentions for Health Sciences Acquisitions Co. 2 and 1 mentions for SEP Acquisition. Health Sciences Acquisitions Co. 2's average media sentiment score of 0.41 beat SEP Acquisition's score of -1.00 indicating that Health Sciences Acquisitions Co. 2 is being referred to more favorably in the news media.
Summary
Health Sciences Acquisitions Co. 2 beats SEP Acquisition on 7 of the 7 factors compared between the two stocks.
Get SEP Acquisition News Delivered to You Automatically
Sign up to receive the latest news and ratings for SEPA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SEPA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
SEP Acquisition Competitors List
Related Companies and Tools
